Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
4
×
boston blog main
life sciences
national blog main
venture capital
4
×
boston top stories
financing
startups
clinical trials
funding
series a
20/20 healthcare partners
abbvie
access biotechnology
access industries
akero therapeutics
amgen ventures
amyotrophic lateral sclerosis
anemia
anthony despasqua
antisense oligonucleotide
apellis pharmaceuticals
aragon pharmaceuticals
atlas ventures
benzodiazepines
biogen
blackstone group
blackstone life sciences
blood diseases
blood disorders
brian macdonald
christian angermayer
columbia university
corey goodman
david goldstein
depression
disc medicine
dolby family ventures
drug development
What
new
4
×
drugs
medicine
neuro
advance
aims
anemia
approach
associated
backed
bags
biotechs
blood
body
capital
carry
cause
cells
ceo
companies
develop
device
dialysis
disc
disease
diseases
enclear
epilepsy
genes
genetic
harmful
having
health
investing
investors
iron
launches
lead
led
limited
Language
unset
Current search:
boston
×
new
×
" venture capital "
×
@xconomy.com
3 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
Disc Medicine Launches With $50M to Advance New Anemia Treatments
